临床试验

REDUCED 1 - Renal Denervation Using Ultrasonic Catheter EmitteD Energy Study /

NCT：NCT05372679 · ACTIVE_NOT_RECRUITING

NCT编号NCT05372679

状态ACTIVE_NOT_RECRUITING

开始日期2022-11-11

SponsorSoniVie Inc. (INDUSTRY)

First posted2022-05-13

Last updated2026-05-20

简要摘要

This is a prospective, multicenter, non-randomized, open-label clinical study of the safety and performance of the TIVUS™ System in subjects with uncontrolled stage 2 hypertension in order to assess the safety and effectiveness of the TIVUS™ System when used for renal artery denervation. The study will assess the acute and chronic safety of the procedure as well as the reduction in 24-hour ambulatory mean systolic blood pressure from baseline to 3 months after the procedure.

官方来源

在 ClinicalTrials.gov 上查看 →

数据来自 ClinicalTrials.gov API。有关最新状态，请参阅官方记录。